The regulation of tenascin expression by tissue microenvironments

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1793, Issue 5, 2009, Pages 888-892

  Tucker, Richard P ^a   Chiquet Ehrismann, Ruth ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

Development; Extracellular matrix; Fibroblast growth factor; Growth factor; Transforming growth factor beta; Tumor stroma

Indexed keywords

CYTOKINE; FIBROBLAST GROWTH FACTOR; HORMONE; PLATELET DERIVED GROWTH FACTOR; SCLEROPROTEIN; TENASCIN; TENASCIN R; TENASCIN W; TENASCIN X; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE; TISSUE CULTURE;

ANIMALS; ENVIRONMENT; FIBROBLAST GROWTH FACTORS; HUMANS; PLATELET-DERIVED GROWTH FACTOR; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION; TENASCIN; TISSUE DISTRIBUTION; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 67349268473     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2008.12.012     Document Type: Review

References (86)

1. Tucker R.P., Drabikowski K., Hess J.F., Ferralli J., Chiquet-Ehrismann R., and Adams J.C. Phylogenetic analysis of the tenascin gene family: evidence of origin early in the chordate lineage. BMC Evol. Biol. 6 (2006) 60
2. Chiquet-Ehrismann R. Tenascins. Int J Biochem Cell Biol. 36 (2004) 986-990
3. Chiquet-Ehrismann R., and Chiquet M. Tenascins: regulation and putative functions during pathological stress. J. Pathol. 200 (2003) 488-499
4. Jones F.S., and Jones P.L. The tenascin family of ECM glycoproteins: structure, function, and regulation during embryonic development and tissue remodeling. Dev. Dyn. 218 (2000) 235-259
5. Bristow J., Carey W., Egging D., and Schalkwijk J. Tenascin-X, collagen, elastin, and the Ehlers-Danlos syndrome. Am. J. Med. Genet. C Semin. Med. Genet. 139 (2005) 24-30
6. Rathjen F.G., Wolff J.M., and Chiquet-Ehrismann R. Restrictin: a chick neural extracellular matrix protein involved in cell attachment co-purifies with the cell recognition molecule F11. Development 113 (1991) 151-164
7. Scherberich A., Tucker R.P., Samandari E., Brown-Luedi M., Martin D., and Chiquet-Ehrismann R. Murine tenascin-W: a novel mammalian tenascin expressed in kidney and at sites of bone and smooth muscle development. J. Cell Sci. 117 (2004) 571-581
8. Scherberich A., Tucker R.P., Degen M., Brown-Luedi M., Andres A.C., and Chiquet-Ehrismann R. Tenascin-W is found in malignant mammary tumors, promotes alpha8 integrin-dependent motility and requires p38MAPK activity for BMP-2 and TNF-alpha induced expression in vitro. Oncogene 24 (2005) 1525-1532
9. Degen M., Brellier F., Kain R., Ruiz C., Terracciano L., Orend G., and Chiquet-Ehrismann R. Tenascin-W is a novel marker for activated tumor stroma in low-grade human breast cancer and influences cell behavior. Cancer Res. 67 (2007) 9169-9179
10. Degen M., Brellier F., Schenk S., Driscoll R., Zaman K., Stupp R., Tornillo L., Terracciano L., Chiquet-Ehrismann R., Rüegg C., and Seelentag W. Tenascin-W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patients. Int. J. Cancer (2008) in press
11. Murphy-Ullrich J.E., Lightner V.A., Aukhil I., Yan Y.Z., Erickson H.P., and Höök M. Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin. J. Cell Biol. 115 (1991) 1127-1136
12. Pesheva P., Probstmeier R., Skubitz A.P., McCarthy J.B., Furcht L.T., and Schachner M. Tenascin-R (J1 160/180) inhibits fibronectin-mediated cell adhesion-functional relatedness to tenascin-C. J. Cell Sci. 107 (1994) 2323-2333
13. Tucker R.P., Hagios C., Santiago A., and Chiquet-Ehrismann R. Tenascin-Y is concentrated in adult nerve roots and has barrier properties in vitro. J. Neurosci. Res. 66 (2001) 439-447
14. Trebaul A., Chan E.K., and Midwood K.S. Regulation of fibroblast migration by tenascin-C. Biochem Soc Trans. 35 (2007) 695-697
15. Meloty-Kapella C.V., Degen M., Chiquet-Ehrismann R., and Tucker R.P. Avian tenascin-W: expression in smooth muscle and bone, and effects on calvarial cell spreading and adhesion in vitro. Dev. Dyn. 235 (2006) 1532-1542
16. Ruiz C., Huang W., Hegi M.E., Lange K., Hamou M.F., Fluri E., Oakeley E.J., Chiquet-Ehrismann R., and Orend G. Growth promoting signaling by tenascin-C. Cancer Res. 64 (2004) 7377-7385
17. Midwood K.S., and Schwarzbauer J.E. Tenascin-C modulates matrix contraction via focal adhesion kinase- and Rho-mediated signaling pathways. Mol. Biol. Cell. 13 (2002) 3601-3613
18. Huang W., Chiquet-Ehrismann R., Moyano J.V., Garcia-Pardo A., and Orend G. Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation. Cancer Res. 61 (2001) 8586-8594
19. Midwood K.S., Valenick L.V., Hsia H.C., and Schwarzbauer J.E. Coregulation of fibronectin signaling and matrix contraction by tenascin-C and syndecan-4. Mol. Biol. Cell. 15 (2004) 5670-5677
20. Orend G., Huang W., Olayioye M.A., Hynes N.E., and Chiquet-Ehrismann R. Tenascin-C blocks cell-cycle progression of anchorage-dependent fibroblasts on fibronectin through inhibition of syndecan-4. Oncogene 22 (2003) 3917-3926
21. Lange K., Kammerer M., Hegi M.E., Grotegut S., Dittmann A., Huang W., Fluri E., Yip G.W., Götte M., Ruiz C., and Orend G. Endothelin receptor type B counteracts tenascin-C-induced endothelin receptor type A-dependent focal adhesion and actin stress fiber disorganization. Cancer Res. 67 (2007) 6163-6173
22. Chiquet-Ehrismann R., Mackie E.J., Pearson C.A., and Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47 (1986) 131-139
23. Orend G., and Chiquet-Ehrismann R. Tenascin-C induced signaling in cancer. Cancer Lett. 244 (2006) 143-163
24. Park P.C., Taylor M.D., Mainprize T.G., Becker L.E., Ho M., Dura W.T., Squire J., and Rutka J.T. Transcriptional profiling of medulloblastoma in children. J. Neurosurg. 99 (2003) 534-541
25. Minamitani T., Ariga H., and Matsumoto K. Adhesive defect in extracellular matrix tenascin-X-null fibroblasts: a possible mechanism of tumor invasion. Biol. Pharm. Bull. 25 (2002) 1472-1475
26. Pennison M., and Pasche B. Targeting transforming growth factor-beta signaling. Curr. Opin. Oncol. 19 (2007) 579-585
27. Pearson C.A., Pearson D., Shibahara S., Hofsteenge J., and Chiquet-Ehrismann R. Tenascin: cDNA cloning and induction by TGF-beta. EMBO J. 7 (1988) 2977-2982
28. Tucker R.P., Hammarback J.A., Jenrath D.A., Mackie E.J., and Xu Y. Tenascin expression in the mouse: in situ localization and induction in vitro by bFGF. J. Cell Sci. 104 (1993) 69-76
29. Sakai T., Kawakatsu H., Ohta M., and Saito M. Tenascin induction in tenascin nonproducing carcinoma cell lines in vivo and by TGF-beta 1 in vitro. J. Cell Physiol. 159 (1994) 561-572
30. Maschler S., Grunert S., Danielopol A., Beug H., and Wirl G. Enhanced tenascin-C expression and matrix deposition during Ras/TGF-beta-induced progression of mammary tumor cells. Oncogene 23 (2004) 3622-3633
31. Berking C., Takemoto R., Schaider H., Showe L., Satyamoorthy K., Robbins P., and Herlyn M. Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling. Cancer Res. 61 (2001) 8306-8316
32. Heine U., Munoz E.F., Flanders K.C., Ellingsworth L.R., Lam H.Y., Thompson N.L., Roberts A.B., and Sporn M.B. Role of transforming growth factor-beta in the development of the mouse embryo. J. Cell Biol. 105 (1987) 2861-2876
33. Chimal-Monroy J., and Díaz de León L. Expression of N-cadherin, N-CAM, fibronectin and tenascin is stimulated by TGF-beta1, beta2, beta3 and beta5 during the formation of precartilage condensations. Int. J. Dev. Biol. 43 (1999) 59-67
34. Vollmer G., Tan M.I., Wünsche W., and Frank K. Expression of tenascin-C by human endometrial adenocarcinoma and stroma cells: heterogeneity of splice variants and induction by TGF-beta. Biochem. Cell Biol. 75 (1997) 759-769
35. Tucker R.P., Spring J., Baumgartner S., Martin D., Hagios C., Poss P.M., and Chiquet-Ehrismann R. Novel tenascin variants with a distinctive pattern of expression in the avian embryo. Development 120 (1994) 637-647
36. Fischer D., Tucker R.P., Chiquet-Ehrismann R., and Adams J.C. Cell-adhesive responses to tenascin-C splice variants involve formation of fascin microspikes. Mol. Biol. Cell. 8 (1997) 2055-2075
37. Tsunoda T., Inada H., Kalembeyi I., Imanaka-Yoshida K., Sakakibara M., Okada R., Katsuta K., Sakakura T., Majima Y., and Yoshida T. Involvement of large tenascin-C splice variants in breast cancer progression. Am. J. Pathol. 162 (2003) 1857-1867
38. Akhurst R.J., Lehnert S.A., Faissner A., and Duffie E. TGF beta in murine morphogenetic processes: the early embryo and cardiogenesis. Development 108 (1990) 645-656
39. Yoshida H., Yoshida T., Iizuka T., Sakakura T., and Fujita S. The expression of transforming growth factor beta (TGF-beta) in the synovial membrane of human temporomandibular joint with internal derangement: a comparison with tenascin expression. J. Oral. Rehabil. 26 (1999) 814-820
40. Soini Y., Kamel D., Apaja-Sarkkinen M., Virtanen I., and Lehto V.P. Tenascin immunoreactivity in normal and pathological bone marrow. J. Clin. Pathol. 46 (1993) 218-221
41. Walker R.A., Dearing S.J., and Gallacher B. Relationship of transforming growth factor beta 1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma. Br. J. Cancer. 69 (1994) 1160-1165
42. Wilson K.E., Bartlett J.M., Miller E.P., Smyth J.F., Mullen P., Miller W.R., and Langdon S.P. Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines. Br. J. Cancer. 80 (1999) 685-692
43. Hau P., Kunz-Schughart L.A., Rümmele P., Arslan F., Dörfelt A., Koch H., Lohmeier A., Hirschmann B., Müller A., Bogdahn U., and Bosserhoff A.K. Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas. J. Neurooncol. 77 (2006) 1-7
44. Wehrhan F., Rödel F., Grabenbauer G.G., Amann K., Brückl W., and Schultze-Mosgau S. Transforming growth factor beta 1 dependent regulation of Tenascin-C in radiation impaired wound healing. Radiother. Oncol. 72 (2004) 297-303
45. Kalembeyi I., Inada H., Nishiura R., Imanaka-Yoshida K., Sakakura T., and Yoshida T. Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1. Int. J. Cancer 105 (2003) 53-60
46. Ribatti D., Vacca A., Rusnati M., and Presta M. The discovery of basic fibroblast growth factor/fibroblast growth factor-2 and its role in haematological malignancies. Cytokine Growth Factor Rev. 18 (2007) 327-334
47. Meiners S., Marone M., Rittenhouse J.L., and Geller H.M. Regulation of astrocytic tenascin by basic fibroblast growth factor. Dev. Biol. 160 (1993) 480-493
48. Mahler M., Ferhat L., Gillian A., Ben-Ari Y., and Represa A. Tenascin-C mRNA and tenascin-C protein immunoreactivity increase in astrocytes after activation by bFGF. Cell Adhes. Commun. 4 (1996) 175-186
49. Rettig W.J., Erickson H.P., Albino A.P., and Garin-Chesa P. Induction of human tenascin (neuronectin) by growth factors and cytokines: cell type-specific signals and signalling pathways. J. Cell Sci. 107 (1994) 487-497
50. Suzuki S., Li A.J., Ikemoto M., and Imamura T. Expression of tenascin-C long isoforms is induced in the hypothalamus by FGF-1. Neuroreport 13 (2002) 1041-1045
51. Wilson K.E., Langdon S.P., Lessells A.M., and Miller W.R. Expression of the extracellular matrix protein tenascin in malignant and benign ovarian tumours. Br. J. Cancer 74 (1996) 999-1004
52. Derr L.B., Chiquet-Ehrismann R., Gandour-Edwards R., Spence J., and Tucker R.P. The expression of tenascin-C with the AD1 variable repeat in embryonic tissues, cell lines and tumors in various vertebrate species. Differentiation 62 (1997) 71-82
53. Ghert M.A., Jung S.T., Qi W., Harrelson J.M., Erickson H.P., Block J.A., and Scully S.P. The clinical significance of tenascin-C splice variant expression in chondrosarcoma. Oncology 61 (2001) 306-314
54. Dang C., Gottschling M., Roewert J., Forschner T., Stockfleth E., and Nindl I. Tenascin-C patterns and splice variants in actinic keratosis and cutaneous squamous cell carcinoma. Br. J. Dermatol. 155 (2006) 763-770
55. LaFleur D.W., Fagin J.A., Forrester J.S., Rubin S.A., and Sharifi B.G. Cloning and characterization of alternatively spliced isoforms of rat tenascin. Platelet-derived growth factor-BB markedly stimulates expression of spliced variants of tenascin mRNA in arterial smooth muscle cells. J. Biol. Chem. 269 (1994) 20757-20763
56. Pringle N.P., and Richardson W.D. A singularity of PDGF alpha-receptor expression in the dorsoventral axis of the neural tube may define the origin of the oligodendrocyte lineage. Development 117 (1993) 525-533
57. Tucker R.P., and McKay S.E. The expression of tenascin by neural crest cells and glia. Development 112 (1991) 1031-1039
58. Garcion E., Faissner A., and ffrench-Constant C. Knockout mice reveal a contribution of the extracellular matrix molecule tenascin-C to neural precursor proliferation and migration. Development 128 (2001) 2485-2496
59. Nakamura Y., Esnault S., Maeda T., Kelly E.A., Malter J.S., and Jarjour N.N. Ets-1 regulates TNF-alpha-induced matrix metalloproteinase-9 and tenascin expression in primary bronchial fibroblasts. J. Immunol. 172 (2004) 1945-1952
60. Nakoshi Y., Hasegawa M., Sudo A., Yoshida T., and Uchida A. Regulation of tenascin-C expression by tumor necrosis factor-alpha in cultured human osteoarthritis chondrocytes. J. Rheumatol. (2007) (e-publication)
61. Härkönen E., Virtanen I., Linnala A., Laitinen L.L., and Kinnula V.L. Modulation of fibronectin and tenascin production in human bronchial epithelial cells by inflammatory cytokines in vitro. Am. J. Respir. Cell. Mol. Biol. 13 (1995) 109-115
62. Gratchev A., Kzhyshkowska J., Utikal J., and Goerdt S. Interleukin-4 and dexamethasone counterregulate extracellular matrix remodelling and phagocytosis in type-2 macrophages. Scand. J. Immunol. 61 (2005) 10-17
63. Fässler R., Sasaki T., Timpl R., Chu M.L., and Werner S. Differential regulation of fibulin, tenascin-C, and nidogen expression during wound healing of normal and glucocorticoid-treated mice. Exp. Cell Res. 222 (1996) 111-116
64. Talts J.F., Weller A., Timpl R., Ekblom M., and Ekblom P. Regulation of mesenchymal extracellular matrix protein synthesis by transforming growth factor-beta and glucocorticoids in tumor stroma. J. Cell Sci. 108 (1995) 2153-2162
65. Ekblom M., Fässler R., Tomasini-Johansson B., Nilsson K., and Ekblom P. Downregulation of tenascin expression by glucocorticoids in bone marrow stromal cells and in fibroblasts. J. Cell Biol. 123 (1993) 1037-1045
66. Laitinen A., Altraja A., Kämpe M., Linden M., Virtanen I., and Laitine L.A. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am. J. Respir. Crit. Care Med. 156 (1997) 951-958
67. Weber P., Montag D., Schachner M., and Bernhardt R.R. Zebrafish tenascin-W, a new member of the tenascin family. J. Neurobiol. 35 (1998) 1-16
68. Derr L.B., McKae L.A., and Tucker R.P. The distribution of tenascin-R in the developing avian nervous system. J. Exp. Zool. 280 (1998) 152-164
69. Sakai T., Furukawa Y., Chiquet-Ehrismann R., Nakamura M., Kitagawa S., Ikemura T., and Matsumoto K. Tenascin-X expression in tumor cells and fibroblasts: glucocorticoids as negative regulators in fibroblasts. J. Cell Sci. 109 (1996) 2069-2077
70. Takeda K., Shiba H., Mizuno N., Hasegawa N., Mouri Y., Hirachi A., Yoshino H., Kawaguchi H., and Kurihara H. Brain-derived neurotrophic factor enhances periodontal tissue regeneration. Tissue Eng. 11 (2005) 1618-1629
71. Mishra L., Shetty K., Tang Y., Stuart A., and Byers S.W. The role of TGF-beta and Wnt signaling in gastrointestinal stem cells and cancer. Oncogene 24 (2005) 5775-5789
72. Gallea S., Lallemand F., Atfi A., Rawadi G., Ramez V., Spinella-Jaegle S., Kawai S., Faucheu C., Huet L., Baron R., and Roman-Roman S. Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. Bone 28 (2001) 491-498
73. Runo J.R., and Loyd J.E. Primary pulmonary hypertension. Lancet 361 (2003) 1533-1544
74. Jones P.L., and Rabinovitch M. Tenascin-C is induced with progressive pulmonary vascular disease in rats and is functionally related to increased smooth muscle cell proliferation. Circ. Res. 79 (1996) 1131-1142
75. Ihida-Stansbury K., McKean D.M., Lane K.B., Loyd J.E., Wheeler L.A., Morrell N.W., and Jones P.L. Tenascin-C is induced by mutated BMP type II receptors in familial forms of pulmonary arterial hypertension. Am. J. Physiol. Lung Cell Mol. Physiol. 291 (2006) L694-702
76. Sarasa-Renedo A., Tunç-Civelek V., and Chiquet M. Role of RhoA/ROCK-dependent actin contractility in the induction of tenascin-C by cyclic tensile strain. Exp. Cell Res. 312 (2006) 1361-1370
77. B. Sivasankaran, M. Degen, A. Ghaffari, M.E. Hegi, M.-F. Hamou, M.-C.S. Ionescu, C. Zweifel, M. Tolnay, M. Wasner, S. Mergenthaler, A.R. Miserez, R. Kiss, M.M. Lino, A. Merlo, R. Chiquet-Ehrismann, J.L. Boulay, Tenascin-C is a novel RBPJκ-induced target gene for Notch signaling in gliomas, Cancer Res. (in press).
78. Tavazoie S.F., Alarcón C., Oskarsson T., Padua D., Wang Q., Bos P.D., Gerald W.L., and Massagué J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451 (2008) 147-152
79. Putthoff P., Akyüz N., Kutsche M., Zardi L., Borgmeyer U., and Schachner M. Structure of the murine tenascin-R gene and functional characterisation of the promoter. Biochem. Biophys. Res. Commun. 308 (2003) 940-949
80. Wijesuriya S.D., Bristow J., and Miller W.L. Localization and analysis of the principal promoter for human tenascin-X. Genomics 80 (2002) 443-452
81. McKean D.M., Sisbarro L., Ilic D., Kaplan-Alburquerque N., Nemenoff R., Weiser-Evans M., Kern M.J., and Jones P.L. FAK induces expression of Prx1 to promote tenascin-C-dependent fibroblast migration. J. Cell Biol. 161 (2003) 393-402
82. Watanabe G., Nishimori H., Irifune H., Sasaki Y., Ishida S., Zembutsu H., Tanaka T., Kawaguchi S., Wada T., Hata J., Kusakabe M., Yoshida K., Nakamura Y., and Tokino T. Induction of tenascin-C by tumor-specific EWS-ETS fusion genes. Genes Chromosomes Cancer 36 (2003) 224-232
83. Chiquet-Ehrismann R., Tannheimer M., Koch M., Brunner A., Spring J., Martin D., Baumgartner S., and Chiquet M. Tenascin-C expression by fibroblasts is elevated in stressed collagen gels. J. Cell Biol. 127 (1994) 2093-2101
84. Chiquet-Ehrismann R., Hagios C., and Schenk S. The complexity in regulating the expression of tenascins. Bioessays 17 (1995) 873-878
85. Jinnin M., Ihn H., Asano Y., Yamane K., Trojanowska M., and Tamaki K. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1. Oncogene 23 (2004) 1656-1667
86. Ghatnekar A., and Trojanowska M. GATA-6 is a novel transcriptional repressor of the human Tenascin-C gene expression in fibroblasts. Biochim. Biophys. Acta 1779 (2008) 145-151